Hyperintense basal ganglia on T1 weighted MR images: Case report in Manson's Schistosomiasis with portal-systemic encephalopathy;Hiperintensidade de sinal em T1 dos núcleos da base: Relato de caso na encefalopatia portal sistêmica esquistossomótica

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 A, 1999, Pages 306-310

  Da Costa Machado Jr , Marcos Alberto ^a   Sobrinho, Fernando Pena Gaspar ^a   Oliveira Barbosa, Verônica Aline ^a   Bina, José Carlos ^a   De Sousa Matos, Hugo ^a  

^a NONE

Author keywords

Basal ganglia; Magnetic resonance image; Manganese; Mansonic schistosomiasis; Neuroradiology; Portal systemic encephalopathy

Indexed keywords

MANGANESE;

ADULT; BASAL GANGLION; CASE REPORT; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; REVIEW; SCHISTOSOMA MANSONI;

ADULT; BASAL GANGLIA; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE; SCHISTOSOMIASIS MANSONI;

EID: 0033146994     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000200024     Document Type: Article

References (39)

1. Sherlock S, Summerrskill W H. Portal-systemic encephalophaty: neurological complications of liver disease. Lancet 1954;267:453-457.
2. Inoue E, Hori S, Yoshifumi N et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1901;179:551-555.
3. Kulisevsky J, Pujol J, Deus J, et al. Persistence of MRI hyperintensity of globus pallius in cirrotic patients: a 2 year follow up study. Neurology 1995;45:995-997.
4. Kulisevsky J, Pujol J, Junque C, Deus J et al. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 1993;43:2570-2573.
5. Brunberg JÁ, Kanal E, Hirsch W et al. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR 1991;12:909-914.
6. Maeda H, Sato M, Yoshikawa WA, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1 - weigheted images and elemental concentration in brain. Neuroradiology 1997;39:546-550.
7. Gozzoli L, Ambrogio L, Grasso M, Iperintensita dei nuclei della base nelle sequenze RM T1 -W in un caso di shunt portosistemico senza insufficienza epatica. Riv Neuroradiol 1996;9:493-500.
8. Scott AM, Westrich TJ, Hirsch JD. Hyperintense basal ganglia on T1-weigheted MR images in patients receiving parenteral nutrition. Radiology 1991;181:117-120.
9. Quaghebeur G, Taylor WJ, Kingsley DPE. MRI in children receiving total parenteral nutrition. Neuroradiology 1996;38:680-683.
10. Prata A, Esquitossomose manosini. In Voronesi R. Doenças infecciosas e parasitárias. 8 Ed. Rio de Janeiro: Guanabara Koogan; 1992:838-855.
11. Summerskill WHJ, Davidson EA, Sherlock S, et al. The neuropsychiatric syndrome associatredd with hepatic cirrhosis and as extensive collateral circulation. QJ Med 1956;25:245-266.
12. Matsumoto S, Mori M, Yoshioka K, et al. Effects of portal-systemic shunt embolization on the basal ganglia: MRI. Neuroradiology 1997;39:326-328.
13. Sherlock S. Disease of the liver and biliary system. 7 Ed. Oxford: Blackwell, 1985.
14. Waggoner RW, Malamud N. Wilson's disease in the light of cerebral changes following ordinary acquired liver disorders. J Nerv Ment Dis 1942;96:410-423.
15. Victor M, Adams RD, Cole M. The acquired (non Wilsonian) type of chronic hepatocerebral degeneration. Medicine 1965;44:345-396.
16. Zeneroli ML, Cioni G, Vezzelli C, et al. Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy: evaluation by computed tomography. J Hepatol 1987;4:283-292.
17. Bernthal P, Hays A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 1987;7:107-114.
18. I8. Zeneroli ML, Cioni G. Cooper AJL. Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy: evaluation by computed tomograpy. J Hepatol 1987;4:283-292.
19. Kulisevski J, Pujol J, Grau JM. Pallidal hyperintensity on MRI in cirrhotiv patients: clinical correlations. Hepatology 1992;16:1382-1388.
20. Vymazal J, Babis M, T1 and T2 alterations in the brains of patients with hepatic cirrhosis. Am J Neurorad 1996;17:333-336.
21. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with MRI. Exp Neurol 1989;106:251-258.
22. Krieger D, Krieger S, Jansen O. Gass P. Manganese and chronic hepatic encephalophaty. Lancet 1955;346:270-274.
23. Mirowitz AS, Westrich TJ, Basal banglia signal intensity alterations: rversal after discontinuation of parenteral manganese adminstration . Radiology 1992;185:535-536.
24. Markesbery WR., Ehmann WD, Hossain TIM, Alauddin M. Brain manganese concentrations in human aging and Alzheimer's disease. Neurotoxicology 1984;5:49-58.
25. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50:510-513.
26. Pujol A, Pujol J. Hyperintense globus pallidus on T1 - weighetd MRI in cirrhotic patients in associated with severity of the liver failure. Neurology 1993;43:65-69.
27. Andrade ZA. Hepatic Schistosomiasis morphologic aspects. Reprint. In Popper H, Schaffner F (eds). Progress in liver diseases, 1964.
28. Andrade ZA, Bina JC. A patologia da forma hepato-esplénica da esquistossomose mansoni em sua forma avançada. Mem Inst Oswaldo Cruz 1983;78:285-305.
29. Symmers W St C. Note on a new form of liver cirrhosis due to the presence of the ova of bilharzia haemalobia. J Path Bact 1904;9:237-239.
30. Greenberb DM, Copp DH, Cuthbertson EM. Studies in mineral metabolism with aid of artificial radioactive isotopes;distribution and excretion particulary by way of bile, of iron, cobalt and manganese. J Biol Chem 1943;147:749-756.
31. Larsen NA, Pakkenberg H, Damsgaard E, Heydorn K. Topographical distribution of arsenic, manganese, and selenium in the normal human brain. J Nerol Sci 1979;42:407-416.
32. Newland MC, Cox C, Hamada R. The clearance of manganese chloride in the primate. Fundam Appl Toxicol 1987;9:314-328.
33. Langston JW. Intustrial toxins in parkinsonism. Annu Course American Academy of Neurology. Vol IV, Course 440, San Fransisco, 1996.
34. Huang CC, Lu CS. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483
35. Donaldson J, La Bella FS, Gesser D. Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 1981;2:53-64.
36. Mirowitz SA, Westrich TJ, Hirsch JD. Basal ganglia signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992;185:535-536.
37. Kulisevsky J., Pujol J. Persistencee of MRI hyperintnsity of the globus pallidus in cirrhotic patients: a 2 years folllow-up study. Neurology 1995;45:995-997.
38. Devenyi AG, Barron TF. Dystonia, hiperintense basal ganglia, and high wholwe blood manganese level in Alagille's syndrome. Gastroenterology 1994;106:1068-1071
39. Luttmann S, Husstedt I W, Schuiere. High-signal lesions in the midbrain on T1 -weighted MRI in na HIV-infected patient. Neuroradiology 1997;39:136-138.